Legal Opinion
In re Propranolol Antitrust Litigation
District Court, S.D. New York
Decided April 6, 2017No. 16-CV-09901 (JSR)PublishedCited by 25 opinions
1Opinion of the Court
*715OPINION AND ORDER
JED S. RAKOFF, United States District Judge
Plaintiffs FKW Holdings and' Cesar Castillo (the “Direct Purchasers”) and Sergeants Benevolent Association Health & Welfare Fund and American Federation of State, County and Municipal Employees District Council 37 Health & Security Plan (the “End-Payors”) bring putative nationwide class actions alleging that defendants illegally conspired to fix the price of the generic drug, propranolol hydrochloride (“Propranolol”). By Bottom-Line Order dated February 27, 2017 (the “Bottom-Line Order”), the Court denied the motion by defendants…
2Cases cited48 opinions
- Bell Atlantic Corp. v. TwomblySupreme Court of the United States · 2007
- Burger King Corp. v. RudzewiczSupreme Court of the United States · 1985
- Warth v. SeldinSupreme Court of the United States · 1975
- Daimler AG v. BaumanSupreme Court of the United States · 2014
- Associated General Contractors of California, Inc. v. California State Council of CarpentersSupreme Court of the United States · 1983
43 more not listed; retrieve them via the Exa API.
3Cited by25 opinions
- In re Lipitor Antitrust Litig.District Court, D. New Jersey · 2018
- In re Generic Pharm. Pricing Antitrust Litig.District Court, E.D. Pennsylvania · 2019
- City of Rockford v. Mallinckrodt ARD, Inc.District Court, E.D. Illinois · 2019
- In re Generic Pharm. Pricing Antitrust Litig.District Court, E.D. Pennsylvania · 2018
- In re EpipenDistrict Court, D. Kansas · 2018
20 more not listed; retrieve them via the Exa API.